Litcius/Paper detail

PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study

Julie Delyon, Lucie Biard, Marion Renaud, Matthieu Resche-Rigon, Jérôme Le Goff, Stéphane Dalle, Valentine Heidelberger, Laetitia Da Meda, Laurie Toullec, Guislaine Carcelain, Samia Mourah, Sophie Caillat-Zucman, Vincent Allain, Maxime Battistella, Céleste Lebbe

2022The Lancet Oncology60 citationsDOI

Topics & Concepts

PembrolizumabMedicineBlockadeInternal medicineOncologyPhases of clinical researchPhase (matter)DiseaseImmunologyAntibodyViral-associated cancers and disordersLymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and Treatment
PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study | Litcius